📚 The Pathogen and Immune Mechanisms of AIDS | 艾滋病的病原与免疫机制
Acquired Immunodeficiency Syndrome (AIDS) is one of the most thoroughly studied diseases in modern biology, representing a profound interaction between a viral pathogen and the human immune system. Understanding its causative agent, the Human Immunodeficiency Virus (HIV), and the precise mechanisms by which it dismantles immune defence, is essential for any A-Level Biology student.
获得性免疫缺陷综合征（艾滋病）是现代生物学中研究最为深入的疾病之一，它代表了病毒病原体与人体免疫系统之间深刻的相互作用。理解其病原体——人类免疫缺陷病毒（HIV），以及它瓦解免疫防御的精确机制，对任何A-Level生物学生都至关重要。
1. The Pathogen: Structure of HIV | 病原体：HIV的结构
HIV is a retrovirus belonging to the family Retroviridae. Its structure is highly specialised for infecting host cells. The virion is roughly spherical, approximately 120 nm in diameter, and consists of a lipid envelope derived from the host cell membrane during budding.
HIV是一种逆转录病毒，属于逆转录病毒科。其结构高度特化，专门用于感染宿主细胞。病毒颗粒大致呈球形，直径约120纳米，由出芽时源自宿主细胞膜的脂质包膜组成。
The viral envelope contains two crucial glycoproteins: gp120, which protrudes from the surface, and gp41, which is transmembrane. These are essential for viral attachment and fusion with host cells. Beneath the envelope lies the matrix protein p17, and deeper still, the capsid protein p24 forms a conical core housing the viral genome.
病毒包膜包含两种关键的糖蛋白：gp120（突出于表面）和 gp41（跨膜蛋白）。它们对病毒附着并与宿主细胞融合至关重要。在包膜下方是基质蛋白p17，更深处是衣壳蛋白p24，形成锥形核心，包裹着病毒基因组。
The viral genome consists of two identical single-stranded RNA molecules. It also carries three key enzymes: reverse transcriptase, which copies RNA into DNA; integrase, which inserts viral DNA into the host genome; and protease, which cleaves polyproteins into functional viral proteins during maturation.
病毒基因组由两条相同的单链RNA分子组成。它还携带三种关键酶：逆转录酶（将RNA逆转录为DNA）、整合酶（将病毒DNA插入宿主基因组）以及蛋白酶（在成熟过程中将多聚蛋白裂解为功能性病毒蛋白）。
2. Transmission Routes | 传播途径
HIV is transmitted through specific body fluids: blood, semen, vaginal fluids, rectal fluids, and breast milk. The most common routes are unprotected sexual intercourse, sharing contaminated needles among intravenous drug users, mother-to-child transmission during pregnancy, childbirth, or breastfeeding, and contaminated blood transfusions.
HIV通过特定体液传播：血液、精液、阴道分泌物、直肠液和母乳。最常见的传播途径是无保护的性行为、静脉注射毒品者共用受污染的针头、妊娠/分娩/母乳喂养期间的母婴传播，以及受污染的输血。
It is critical to note that HIV is not transmitted through casual contact, hugging, shaking hands, sharing food, coughing, sneezing, or insect bites. The virus is extremely fragile outside the body and cannot survive prolonged exposure to air. Understanding these transmission routes is fundamental to designing effective prevention strategies.
必须指出的是，HIV不会通过日常接触、拥抱、握手、共享食物、咳嗽、打喷嚏或蚊虫叮咬传播。病毒在体外极其脆弱，无法在空气中长时间存活。理解这些传播途径是制定有效预防策略的基础。
3. Life Cycle of HIV | HIV的生命周期
The HIV life cycle can be divided into seven distinct stages, each representing a potential target for antiretroviral therapy.
HIV的生命周期可分为七个不同阶段，每个阶段都代表抗逆转录病毒治疗的潜在靶点。
Stage 1 – Attachment: The gp120 glycoprotein binds to the CD4 receptor on the surface of helper T cells (CD4⁺ T cells) and macrophages. This binding alone is insufficient for entry; gp120 must also interact with a co-receptor, typically CCR5 on macrophages or CXCR4 on T cells.
阶段1 – 附着：gp120糖蛋白与辅助性T细胞（CD4⁺ T细胞）和巨噬细胞表面的CD4受体结合。仅此结合不足以进入细胞；gp120还必须与辅助受体相互作用，通常是巨噬细胞上的CCR5或T细胞上的CXCR4。
Stage 2 – Fusion: Conformational changes in gp120 expose gp41, which inserts its hydrophobic fusion peptide into the host cell membrane, bringing the viral envelope and cell membrane together, allowing the capsid to enter the cytoplasm.
阶段2 – 融合：gp120的构象变化暴露了gp41，gp41将其疏水性融合肽插入宿主细胞膜，使病毒包膜和细胞膜靠拢，允许衣壳进入细胞质。
Stage 3 – Reverse Transcription: Once inside the cytoplasm, reverse transcriptase copies the viral RNA into double-stranded DNA. This enzyme is highly error-prone, leading to a high mutation rate, which complicates vaccine development and drug resistance.
阶段3 – 逆转录：进入细胞质后，逆转录酶将病毒RNA复制为双链DNA。该酶极易出错，导致高突变率，这使疫苗开发和耐药性问题变得复杂。
Stage 4 – Integration: The viral DNA, now called proviral DNA, is transported into the nucleus, where integrase catalyses its insertion into the host cell's chromosomal DNA. Once integrated, the provirus remains permanently in the host genome.
阶段4 – 整合：病毒DNA（现称为前病毒DNA）被转运至细胞核，整合酶催化其插入宿主细胞染色体DNA。一旦整合，前病毒就永久保留在宿主基因组中。
RNA → DNA → integrated provirus → mRNA → viral proteins → new virions
Stage 5 – Transcription and Translation: The integrated provirus is transcribed by host RNA polymerase, producing viral mRNA. This mRNA is spliced and translated by host ribosomes to produce viral polyproteins.
阶段5 – 转录和翻译：整合的前病毒被宿主RNA聚合酶转录，产生病毒mRNA。该mRNA被剪接并由宿主核糖体翻译，产生病毒多聚蛋白。
Stage 6 – Assembly: New viral RNA and viral proteins migrate to the cell membrane. gp120 and gp41 are transported to the cell surface, where they are incorporated into the budding virion.
阶段6 – 组装：新的病毒RNA和病毒蛋白迁移至细胞膜。gp120和gp41被转运至细胞表面，在新出芽的病毒粒子上组装。
Stage 7 – Budding and Maturation: The immature virion buds from the host cell, acquiring its lipid envelope. Protease then cleaves the polyproteins into functional structural proteins and enzymes, producing a mature, infectious virion capable of infecting new cells.
阶段7 – 出芽和成熟：未成熟的病毒粒子从宿主细胞出芽，获得脂质包膜。随后蛋白酶将多聚蛋白裂解为功能性结构蛋白和酶，产生能够感染新细胞的成熟、具有感染性的病毒粒子。
4. Target Cells and Immune Evasion | 靶细胞与免疫逃逸
HIV exhibits a strong tropism for cells expressing the CD4 receptor. The primary target is the CD4⁺ helper T cell (Th cell), which orchestrates virtually all adaptive immune responses. HIV also infects macrophages, dendritic cells, and microglial cells in the brain.
HIV对表达CD4受体的细胞表现出强烈的嗜性。主要靶细胞是CD4⁺辅助性T细胞（Th细胞），它协调着几乎所有适应性免疫应答。HIV还感染巨噬细胞、树突状细胞和脑中的小胶质细胞。
The destruction of CD4⁺ T cells is the central pathological feature of HIV infection. Normally, the human body produces approximately 1–2 billion new CD4⁺ T cells daily, maintaining a healthy count of 500–1500 cells/mm³ of blood. HIV infection disrupts this balance in several ways:
CD4⁺ T细胞的破坏是HIV感染的核心病理特征。正常情况下，人体每天产生约10–20亿个新的CD4⁺ T细胞，维持每立方毫米血液500–1500个细胞的健康水平。HIV感染通过多种方式打破这种平衡：
Direct cytopathic effects: Massive viral budding damages the cell membrane, leading to cell lysis.
直接细胞病变效应：大量病毒出芽破坏细胞膜，导致细胞裂解。
Syncytia formation: Infected cells fuse with uninfected CD4⁺ cells, forming giant multinucleated cells that die rapidly.
合胞体形成：受感染细胞与未感染CD4⁺细胞融合，形成巨大的多核细胞，迅速死亡。
Apoptosis: Free gp120 shed from virions can cross-link CD4 receptors on uninfected cells, triggering programmed cell death.
细胞凋亡：从病毒粒子脱落的游离gp120可交联未感染细胞上的CD4受体，触发程序性细胞死亡。
Cytotoxic killing: HIV-specific CD8⁺ cytotoxic T cells recognise viral peptides on infected cells and kill them.
细胞毒性杀伤：HIV特异性CD8⁺细胞毒性T细胞识别受感染细胞上的病毒肽并杀死它们。
Chronic immune activation: Persistent viral replication causes continuous immune stimulation, exhausting the regenerative capacity of the immune system.
慢性免疫激活：持续的病毒复制导致免疫系统持续受到刺激，耗尽了免疫系统的再生能力。
5. The Immune Response to HIV | 对HIV的免疫应答
The host immune system mounts an aggressive but ultimately inadequate response to HIV. Understanding this dual nature—robust yet ineffective—is key to grasping the pathogenesis of AIDS.
宿主免疫系统对HIV发起攻击性的但最终无效的应答。理解这种双重性——强烈却无效——是掌握艾滋病发病机制的关键。
Innate immunity: Natural killer (NK) cells are activated early in infection and can kill HIV-infected cells through antibody-dependent cell-mediated cytotoxicity. Dendritic cells capture viral antigens and present them to T cells in lymph nodes, initiating adaptive immunity. However, HIV can infect dendritic cells themselves, converting antigen-presenting cells into viral factories.
先天免疫：自然杀伤（NK）细胞在感染早期被激活，可通过抗体依赖性细胞介导的细胞毒作用杀死HIV感染细胞。树突状细胞捕获病毒抗原并在淋巴结中呈递给T细胞，启动适应性免疫。然而，HIV本身可以感染树突状细胞，将抗原呈递细胞转化为病毒工厂。
Humoral immunity: B cells produce neutralising antibodies against gp120 and gp41. These antibodies can neutralise free virus particles in the blood. However, their effectiveness is limited by:
体液免疫：B细胞产生针对gp120和gp41的中和抗体。这些抗体可以中和血液中的游离病毒颗粒。然而，其有效性受到以下因素的限制：
The high mutation rate of HIV results in constant changes in envelope glycoproteins, allowing escape from existing antibodies.
高突变率导致包膜糖蛋白不断变化，使病毒逃逸现有抗体的识别。
Glycosylation of gp120 shields many epitopes from antibody access.
gp120的糖基化屏蔽了许多表位，使抗体无法接近。
Cell-to-cell transmission of HIV can occur without exposing the virus to circulating antibodies.
HIV可通过细胞间直接传播，无需将病毒暴露于循环抗体。
Cell-mediated immunity: CD8⁺ cytotoxic T lymphocytes (CTLs) recognise viral peptides presented on MHC class I molecules and kill infected cells. Early in infection, a vigorous CTL response significantly reduces viral load. However, viral mutation generates escape variants that are no longer recognised by existing CTL clones.
细胞免疫：CD8⁺细胞毒性T淋巴细胞（CTL）识别MHC I类分子上呈递的病毒肽并杀死受感染细胞。感染早期，强烈的CTL应答显著降低病毒载量。然而，病毒突变产生了不再被现有CTL克隆识别的逃逸变异株。
After the acute phase, a precarious equilibrium called the viral set point is established. The viral set point is a strong predictor of disease progression: patients with a lower set point progress to AIDS more slowly.
急性期之后，建立了一种不稳定的平衡状态，称为病毒设定点。病毒设定点是疾病进展的强预测因子：设定点较低的患者进展为艾滋病较慢。
6. Clinical Stages of HIV Infection | HIV感染的临床分期
HIV infection follows a predictable clinical course, classically divided into three phases.
HIV感染遵循可预测的临床进程，典型分为三个阶段。
Phase 1 – Acute Infection (Primary HIV Infection): Occurs 2–4 weeks after exposure. Patients may experience flu-like symptoms: fever, sore throat, lymphadenopathy, and rash. During this phase, viral load peaks at millions of copies per millilitre, and CD4⁺ T-cell count transiently drops. The high viral load makes the patient highly infectious.
阶段1 – 急性感染（原发性HIV感染）：暴露后2–4周发生。患者可能出现流感样症状：发热、咽喉痛、淋巴结肿大和皮疹。此阶段病毒载量达到每毫升数百万拷贝的高峰，CD4⁺ T细胞计数短暂下降。高病毒载量使患者具有高度传染性。
Phase 2 – Chronic Latency (Clinical Latency Phase): Lasts an average of 8–10 years without treatment. The patient may be asymptomatic or have mild persistent lymphadenopathy. Viral replication continues at a low level, and CD4⁺ T-cell counts gradually decline from normal levels to below 500 cells/mm³. This phase reflects the ongoing battle between the immune system and the virus.
阶段2 – 慢性潜伏期（临床潜伏期）：不经治疗平均持续8–10年。患者可能无症状或仅有轻度持续性淋巴结肿大。病毒以低水平持续复制，CD4⁺ T细胞计数从正常水平逐渐下降至每立方毫米500个以下。此阶段反映了免疫系统与病毒之间的持续战斗。
Phase 3 – AIDS (Acquired Immunodeficiency Syndrome): When CD4⁺ T-cell count falls below 200 cells/mm³, the cell-mediated immune system is severely compromised. The patient becomes vulnerable to opportunistic infections and certain malignancies. The diagnosis of AIDS is made when specific opportunistic conditions appear or the CD4 count drops below this threshold.
阶段3 – 艾滋病（获得性免疫缺陷综合征）：当CD4⁺ T细胞计数降至每立方毫米200个以下时，细胞介导的免疫系统严重受损。患者变得易受机会性感染和某些恶性肿瘤的侵害。当出现特定的机会性感染疾病或CD4计数低于此阈值时，即可诊断艾滋病。
7. Opportunistic Infections and Disease Progression | 机会性感染与疾病进展
The hallmark of AIDS is susceptibility to opportunistic infections—diseases caused by pathogens that do not normally cause illness in people with healthy immune systems. The specific infections that arise reflect the degree of immunosuppression.
艾滋病的标志是易受机会性感染——由正常情况下不会在免疫系统健康人群中引起疾病的病原体所致的感染。出现的特定感染反映了免疫抑制的程度。
Common opportunistic conditions associated with AIDS include:
与艾滋病相关的常见机会性感染和疾病包括：
Pneumocystis jirovecii pneumonia (PCP): A fungal lung infection, the most common AIDS-defining illness.
卡氏肺孢子菌肺炎（PCP）：一种肺部真菌感染，是最常见的艾滋病定义性疾病。
Candidiasis: Fungal infection of the mouth (thrush) and oesophagus caused by Candida albicans.
念珠菌病：由白色念珠菌引起的口腔（鹅口疮）和食管真菌感染。
Tuberculosis (TB): The leading cause of death in HIV-positive individuals worldwide, particularly in sub-Saharan Africa.
结核病：全球HIV阳性人群的主要死因，尤其是撒哈拉以南非洲地区。
Kaposi's sarcoma: A vascular tumour caused by Human Herpesvirus 8 (HHV-8), appearing as purple skin lesions.
卡波西肉瘤：由人类疱疹病毒8型（HHV-8）引起的血管肿瘤，表现为紫色皮肤病变。
Cytomegalovirus (CMV) retinitis: Viral infection causing blindness in late-stage AIDS.
巨细胞病毒（CMV）视网膜炎：在艾滋病晚期引起失明的病毒感染。
Toxoplasmosis: A parasitic brain infection caused by Toxoplasma gondii.
弓形虫病：由弓形虫引起的脑部寄生虫感染。
Only in the late stage of AIDS, when CD4⁺ T-cell counts fall below 50 cells/mm³, does the patient succumb to overwhelming infections. This quantitative relationship between CD4⁺ count and disease manifestation is a powerful example of the causal role of CD4⁺ T cells in immune protection.
仅在艾滋病晚期，当CD4⁺ T细胞计数降至每立方毫米50个以下时，患者才会死于难以控制的感染。CD4⁺计数与疾病表现之间的这种定量关系是CD4⁺ T细胞在免疫保护中因果作用的强有力例证。
8. Antiretroviral Therapy (ART) | 抗逆转录病毒治疗
While there is no curative treatment for HIV infection, Highly Active Antiretroviral Therapy (HAART) has transformed HIV from a fatal disease into a manageable chronic condition. ART involves a combination of drugs targeting different stages of the viral life cycle.
虽然HIV感染目前尚无根治性治疗方法，但高效抗逆转录病毒治疗（HAART）已将HIV从致命疾病转变为可控的慢性病。ART采用针对病毒生命周期不同阶段的药物组合。
Major drug classes include:
主要药物类别包括：
Reverse transcriptase inhibitors (NRTIs and NNRTIs): NRTIs (e.g., AZT, tenofovir) are nucleoside analogues that act as chain terminators, halting DNA synthesis. NNRTIs (e.g., efavirenz) bind directly to the enzyme, changing its conformation.
逆转录酶抑制剂（NRTIs和NNRTIs）：NRTIs（如AZT、替诺福韦）是核苷类似物，作为链终止剂，终止DNA合成。NNRTIs（如依非韦伦）直接结合酶，改变其构象。
Protease inhibitors (PIs): (e.g., ritonavir) Block protease activity, preventing the maturation of new virions into infectious particles.
蛋白酶抑制剂（PIs）：（如利托那韦）阻断蛋白酶活性，阻止新病毒粒子成熟为具有感染性的颗粒。
Integrase inhibitors: (e.g., raltegravir) Block the integration of viral DNA into the host genome.
整合酶抑制剂：（如拉替拉韦）阻断病毒DNA整合入宿主基因组。
Entry/fusion inhibitors: (e.g., maraviroc, enfuvirtide) Prevent the virus from entering host cells.
进入/融合抑制剂：（如马拉韦罗、恩夫韦肽）阻止病毒进入宿主细胞。
ART cannot eradicate HIV because the provirus remains latently integrated in resting memory CD4⁺ T cells—a viral reservoir that persists for decades. However, ART suppresses viral replication to undetectable levels, allowing CD4⁺ T-cell counts to recover.
ART无法根除HIV，因为前病毒以潜伏状态整合在静息记忆性CD4⁺ T细胞中——这是一个持续数十年的病毒储存库。然而，ART能将病毒复制抑制到不可检测的水平，使CD4⁺ T细胞计数得以恢复。
A crucial public health finding is U=U (Undetectable = Untransmittable): when an HIV-positive person on ART maintains an undetectable viral load, they cannot sexually transmit the virus to partners. This concept has profound implications for stigma reduction and epidemic control.
一个关键的公共卫生发现是U=U（不可检测=不传染）：当HIV阳性者通过ART维持病毒载量不可检测时，他们不会通过性传播将病毒传给伴侣。这一概念对减少污名化和流行控制具有深远意义。
9. Prevention and Vaccination Challenges | 预防与疫苗挑战
Effective prevention strategies operate at multiple levels. Pre-exposure prophylaxis (PrEP) involves taking ART drugs by HIV-negative individuals at high risk, reducing infection risk by over 90%. Post-exposure prophylaxis (PEP) is a 28-day course of ART administered within 72 hours of potential exposure. Harm reduction programmes, including needle exchange, have proven highly effective in reducing transmission among intravenous drug users.
有效的预防策略在多个层面运作。暴露前预防（PrEP）即高危HIV阴性个体服用ART药物，可将感染风险降低90%以上。暴露后预防（PEP）是在可能暴露后72小时内进行的28天ART疗程。减少危害计划（包括针具交换）已被证明能有效减少静脉吸毒者中的传播。
Developing an effective HIV vaccine has been extraordinarily difficult. The key obstacles are:
开发有效的HIV疫苗极为困难。主要障碍包括：
Viral diversity: HIV mutates faster than influenza; globally, multiple subtypes (clades) circulate simultaneously, each differing by up to 30% in envelope sequence.
病毒多样性：HIV的突变速度快于流感病毒；全球同时流行多种亚型（分支），其包膜序列差异可达30%。
Envelope shielding: The gp120 protein is heavily glycosylated, physically blocking antibody access to conserved epitopes.
包膜屏蔽：gp120蛋白被高度糖基化，物理性阻断抗体进入保守表位。
No natural immunity: Individuals who recover from most viral infections develop lifelong immunity. No one has ever cleared HIV infection naturally, providing no template for vaccine design.
无天然免疫模板：大多数病毒感染康复者可产生终生免疫。但从未有人能够天然清除HIV感染，这使疫苗设计缺乏模板。
Integration into host genome: The latent proviral reservoir is invisible to the immune system and cannot be eliminated by antibodies.
整合入宿主基因组：潜伏的前病毒储存库对免疫系统不可见，无法被抗体清除。
10. Diagnostic Methods | 诊断方法
Accurate diagnosis is essential for treatment and prevention. Diagnostic tests detect either antibodies, viral antigens, or viral nucleic acids.
准确诊断对于治疗和预防至关重要。诊断检测可检测抗体、病毒抗原或病毒核酸。
Antibody tests (ELISA): This screening test detects antibodies against HIV in blood or saliva. It is highly sensitive but cannot detect infection during the window period (2–4 weeks after infection before seroconversion). Positive results are confirmed with a Western blot or immunofluorescence assay.
抗体检测（ELISA）：该筛查试验检测血液或唾液中的HIV抗体。它灵敏度高，但无法在窗口期（感染后2–4周血清转化前）检测出感染。阳性结果须用Western blot或免疫荧光试验确认。
Antigen tests (p24): Detect the viral p24 capsid protein, which appears in blood 2–3 weeks after infection—earlier than antibodies. This has shortened the diagnostic window significantly.
抗原检测（p24）：检测病毒p24衣壳蛋白，在感染后2–3周出现在血液中——早于抗体。这大大缩短了诊断窗口期。
Nucleic acid tests (PCR): Amplify and detect HIV RNA or proviral DNA. These are the most sensitive tests, useful for early diagnosis, screening of blood products, and monitoring viral load during treatment.
核酸检测（PCR）：扩增并检测HIV RNA或前病毒DNA。这是最灵敏的检测方法，适用于早期诊断、血液制品筛查和治疗期间的病毒载量监测。
| Test | 检测 | Target | 靶标 | Detection Time | 检出时间 |
| ELISA | 酶联免疫 | Antibodies | 抗体 | 3–12 weeks | 3–12周 |
| p24 antigen | p24抗原 | Viral capsid protein | 病毒衣壳蛋白 | 2–3 weeks | 2–3周 |
| PCR | 聚合酶链反应 | Viral RNA / DNA | 病毒RNA/DNA | ≈ 10 days | 约10天 |
Published by TutorHao | Biology Revision Series | aleveler.com
更多咨询请联系16621398022（同微信）
或截图后用「扫一扫 → 相册」选择本图